Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock, $0.0001 par value | 3.28M | $5.67M | $1.73 | Jun 13, 2024 | By Funds |
Icosavax, Inc. | Director | Common Stock | 257K | $4.02M | $15.67 | Aug 2, 2021 | Indirect |
Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
Corvus Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15K | Jun 13, 2024 | Direct | ||
Icosavax, Inc. | Director | Series A-1 Preferred Stock | 0 | Aug 2, 2021 | Indirect | ||
Icosavax, Inc. | Director | Series B-1 Preferred Stock | 0 | Aug 2, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRVS | Corvus Pharmaceuticals, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director, 10%+ Owner |
CRVS | Corvus Pharmaceuticals, Inc. | Dec 6, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Director, 10%+ Owner |
CRVS | Corvus Pharmaceuticals, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director, 10%+ Owner |
CRVS | Corvus Pharmaceuticals, Inc. | Aug 11, 2022 | 1 | $0 | 4 | Aug 15, 2022 | Director, 10%+ Owner |
CRVS | Corvus Pharmaceuticals, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director, 10%+ Owner |
APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
CRVS | Corvus Pharmaceuticals, Inc. | Sep 9, 2021 | 1 | $0 | 4 | Sep 13, 2021 | Director, 10%+ Owner |
ICVX | Icosavax, Inc. | Aug 2, 2021 | 22 | $2M | 4 | Aug 3, 2021 | Director |
ICVX | Icosavax, Inc. | Jul 28, 2021 | 0 | $0 | 3 | Jul 28, 2021 | Director, 10%+ Owner |
CRVS | Corvus Pharmaceuticals, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director, 10%+ Owner |
APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |